At 19 weeks 6 days ultrasonography of a 31-year-old G2P1L1 revealed a small echogenic area seen in the subvalvular apparatus of the mitral valve (anterior mitral leaflet) suggestive of cardiac rhabdomyoma (CR). At 28 weeks of gestation there was mild increase in the size of the CR (13 × 6 mm). There was no evidence of hemodynamic compromise. The interval growth of the fetus was satisfactory. The family tree of three generations was examined and revealed no evidence of Tuberous Sclerosis. She delivered a live 34 weeks 2.2 kg male baby with 8 and 9 Apgar scores at 5 and 10 minutes respectively. Baby suddenly developed cyanosis and died 24 hours after birth. The fetal autopsy confirmed the diagnosis of CR. Genetic analysis of neonatal blood revealed no evidence of TSC mutation suggestive of tuberous sclerosis.
dimension and can be either isolated or multiple. It is usually (5078%) associated with tuberous sclerosis complex (TSC). Multiple CR in a neonate with tuberous sclerosis were first described by Von Recklinghausen in 1862. Cardiac rhabdomyomas can occur sporadically (more than 50%), in association with congenital heart malformations, or in the setting of certain genetic disorders like Down syndrome and basal cell nevus syndrome.
Tuberous sclerosis complex or Bournevilleís disease is a neuroectodermal disorder characterized by the classic triad of mental retar dation (71%), seizures (78%) and adenoma sebaceum (27%), an autosomal dominant-inherited or sporadically occurring disorder characterized by widespread hamartomas that variably involve the brain, kidneys, heart, skin and other organs. 2, 3 Genetic analysis has identified two disease genes: TSC1 on chromosome 9q34 encodes for the protein hamartin, and TSC2 on 16p13 encodes for tuberin. These are tumor suppressor genes that appear to assist in the regulation of growth and differentiation of developing cardiomyocytes by antagonising the mammalian target of rapamycin (mTOR) signaling pathway. 4 Echocardiography or magnetic resonance imaging (MRI) is usually adequate to facilitate the diagnosis of cardiac tumors. Tumor biopsy, with histological assessment, remains as the gold standard for confirmation of the diag nosis.
Cardiac rhabdomyoma usually appears after 20 weeks of gestation, pro gre ssively increases in size up to 32 weeks and later starts regressing. The overall prognosis is dependent on the number, size and location of the lesions as well as the presence or absence of associated anomalies. The manifes tations of a cardiac tumor in fetal life include arrhythmia, congestive heart failure, hydrops and stillbirth. Standard obstetrical management is appropriate for uncomplicated cases. Delivery should take place in a tertiary care center where a pediatric cardiologist is available. In postnatal life, cardiac tumors may affect the integrity and function of the adjacent cardiac structures leading to severely compromised blood flow due to inflow or outflow tract obstruction, cyanosis, murmur, respiratory distress, myocardial dysfunc tion, valvular insufficiency, arrhythmias and sudden death. Prognosis in CR associated with TSC is variable depending on the degree of involvement with 30% mortality by age 5 and 75% mortality by age 20, usually due to central nervous system involvement. Mortality has been reported to be even higher in tuberous sclerosis patients with cardiac involve ment, reportedly up to 50% mortality during the first year of life and 90% mortality by puberty. A definitive diagnosis of TSC as well as careful evaluation of other family members is thus imperative for genetic counseling (Fig. 1 ). 5 Knowing the outcome of these tumors is important in making treatment decisions.
CASe RepORT
We report 34yearold pregnant woman G2P1L1 who pre sented to us in established preterm labor with 4 cm cervical dilatation. Fetal heart rate was 160/min and cardio tocograph was normal. She progressed normally over 5 hours and delivered a live 2.2 kg male baby appropriate for gestational age with 8 and 9 Apgar scores at 5 and 10 minutes respectively. The neonate was shifted to mother side and it tolerated breast feeds well. Baby suddenly developed cyanosis and died 24 hours after birth. Thorough physical examination of the neonate did not reveal any cutaneous manifestations of tuberous sclerosis.
Baby's blood was sent for genetic analysis and the baby was sent for autopsy in view of prenatal diagnosis of cardiac rhabdomyoma. The neonate having isolated single cardiac rhabdomyoma with undiagnosed cardiac dysrhythmia resulting in early neonatal death.
INVeSTIGATIONS

dISCuSSION
The incidence of cardiac tumors is one to two cases per 10,000 live births. 6 Detection is facilitated by routine inclusion of the fourchamber heart view. They occur with equal frequency in the left and right ventricle and the interventricular septum. They are usually associated with TSC in 52 to 86% of patients with rhabdomyomas. Conversely, 50% of children with tuberous sclerosis have rhabdomyomas on echocardiographic evaluation.The risk of recurrence of CR is more in patients with CR associated with TSC. 7 Although the association of multiple cardiac rhabdo myomas with tuberous sclerosis has long been recognized, the association with a single rhabdomyoma is not clear. However, in case of a solitary tumor a careful examination of cardiac chambers should be made in order not to miss smaller lesions elsewhere. Multiple cardiac rhabdomyomas in fetal life may herald the diagnosis of tuberous sclerosis well before the other features of the disease, such as skin signs or seizures, emerge in infancy. 8 The classic clinical triad of tuberous sclerosis includes mental retardation, epilepsy, and facial angiofibromas. The hypopigmented 'mountain ash' macules, angiofibromas, and retinal astrocytic tumors are early features that can occasionally be seen at birth. Other lateoccurring cutaneous manifestations of tuberous sclerosis include subcutaneous nodules, subungual fibromas, linear epidermal nevi, and café au lait pigmentation. Seizures during the neonatal period are not infrequent. Imaging may reveal the presence of cortical or subependymal tubers. Renal angiomyolipomas usually manifest later in life. Detection of multiple cardiac tumors should raise a strong suspicion of rhabdomyoma, hence tuberous sclerosis. In such patients, a detailed family history should be obtained and genetic counseling should be offered. 9 The prenatal diagnosis of solitary rhabdomyoma on ultrasound was confirmed in the index case with the help of biopsy during autopsy of the baby. It was not associated with tuberous sclerosis as was confirmed by karyotyping of the baby.
The outcome of antenatally detected cardiac rhabdo myomas is favorable. Once fetal somatic growth is com pleted, hamartomas lose their mitotic potential and undergo apoptosis. The reported survival rates range from 81 to 92%. Despite the expected shrinkage of these tumors, unexpected fetal loss or neonatal death may occur due to arrhythmias or obstruction of blood flow 10 as happened in the present case. After birth, these tumors can be managed conservatively with echocardiography and ECG monitoring. Following birth, tumor regression is a rule rather than an exception. Complete resolution of more than 80% of the tumors may occur during early childhood. Surgical intervention should be reserved only for sick patients with symptoms of severe obstruction with hemodynamic compromise or hemodynamically significant and intractable arrhythmias that are unresponsive to antiarrhythmic drugs. Operative management involves removal of the intracavitary portion of the tumor without complete excision of the entire lesion. Family screening for tuberous sclerosis is suggested. 11
CONCLuSION
Knowledge of the outcome of affected fetuses and the true incidence of tuberous sclerosis in fetal CR is critical for accurate prenatal counseling and planning of prenatal treatment. CR is benign from the cardiovascular standpoint in most affected foeti. Because the natural history of the CR is one of regression, most patients can be managed conservatively. Finally, it has been suggested that fetuses with a single CR are at lower risk for the development of tuberous sclerosis. 12
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